NIH-funded research R01 grant

Safety of combining erythropoietin and melatonin for very preterm infants with brain bleeds

Official title: Safety of Combinatorial Therapy with Erythropoietin and Melatonin for Preterm Infants with Intraventricular Hemorrhage

Funded at Johns Hopkins University · NIH-11105816 · Data updated 2026-11-12

A Johns Hopkins team is testing a combination of melatonin and erythropoietin to help very preterm babies who have intraventricular hemorrhage avoid longer-term brain problems.

More Preterm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJune 3, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$576,385
NIH project number5R01HD104673-04
Project IDNIH-11105816 on NIH RePORTER

Who could benefit from this research

Could help

Very preterm infants with intraventricular hemorrhage and risk of progressing to hydrocephalus.

Less likely to help

Infants without IVH-related brain injury or those not at risk for PHH may not benefit.

What this research studies

This project focuses on babies born very early who are at high risk for serious brain injury after intraventricular hemorrhage. Researchers are exploring whether giving two safe, familiar medicines together can influence how the brain and its fluid system develop and reduce the need for surgical treatment later on. The study builds on preclinical data showing potential benefits when the medications are given in a steady dosing pattern. If successful, this approach could offer a medical option to protect brain development and possibly reduce complications like hydrocephalus.

Why it matters

Potential benefit: If effective, the combination therapy could lessen the chance of needing brain surgery and improve long-term neurodevelopment in very preterm infants.

How similar studies have gone: Preclinical data suggest the combination can prevent progression from sIVH to PHH in animal models, but human data are needed.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Robinson, Shenandoah — Johns Hopkins University
  • Study coordinator: Robinson, Shenandoah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.